HEALIUS LIMITED — Director's Dealing 2019

Jul 2, 2019

HEALIUS LIMITED ACN 064 530 516 REGISTERED OFFICE: LEVEL 6, 203 PACIFIC HIGHWAY ST LEONARDS NSW 2065 TEL: +61 2 9432 9400

3 July 2019

ASX Limited Market Announcements Office ASX Limited 20 Bridge Street Sydney NSW 2000

Dear Sir/Madam

APPENDIX 3Y – MALCOLM PARMENTER

Enclosed is an Appendix 3Y in respect of the issue of Performance Rights to Malcolm Parmenter, Managing Director and CEO of Healius Limited ( Healius ).

It has become apparent during the preparation of an Appendix 3Y for Dr Parmenter, dealing with the recent issue of ordinary shares (of which Dr Parmenter received a portion), that there has been an oversight in relation to notification of an issue of Performance Rights to Dr Parmenter which occurred on 29 January 2019.

Although a Listing Rule 3.10.3 letter was lodged with ASX on 29 January 2019, covering the issue of Performance Rights to Long-term Incentive Plan participants as a whole (including Dr Parmenter), no Appendix 3Y was lodged at the time in respect of Dr Parmenter.

Please note that the Appendix 3B dated 2 July 2019 is not affected in any respect and no other Directors or other Key Management Personnel of Healius are affected.

Steps have been taken to ensure that the same internal procedures applied to issues of quoted securities are also applied in full to unquoted securities, so that the chances of such errors being repeated are minimised.

Yours sincerely,

==> picture [133 x 49] intentionally omitted <==

Charles Tilley Company Secretary

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity	HEALIUS LIMITED
ABN	24 064 530 516

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Malcolm Parmenter
Date of last notice	15 October 2018

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Direct
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.	As shown in relation to ordinary shares Not applicable in relation to Service Rights Not applicable in relation to Performance Rights
Date of change	29 January 2019
No. of securities held prior to change	59,597 Ordinary shares Malcolm W Parmenter Pty Ltd atf Malcolm W Parmenter Superannuation Fund 51,998 Service Rights Malcolm Parmenter 475,180 Performance Rights Malcolm Parmenter
Class	Performance Rights
Number acquired	804,980

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Number disposed	N/A
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation	N/A
No. of securities held after change	59,597 Ordinary shares Malcolm W Parmenter Pty Ltd atf Malcolm W Parmenter Superannuation Fund 51,998 Service Rights Malcolm Parmenter 1,280,160 Performance Rights Malcolm Parmenter
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy- back	Issue of Performance Rights relating to FY2019 under the Long Term Incentive Plan (granted by Board on 25 January 2019 - refer LR3.10.3 letter dated 29 January 2019), to Managing Director & Chief Executive Officer; pursuant to shareholder approval at 2018 Annual General Meeting. Performance testing period is FY2019-FY2021 inclusive.

Part 2 – Change of director’s interests in contracts Not applicable

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contracts detailed above traded during a+closed period where prior written clearance was required?	Not applicable
If so, was prior written clearance provided to allow the trade to proceed during this period?	Not applicable
If prior written clearance was provided, on what date was this provided?	Not applicable

Charles Tilley Company Secretary Date: 3 July 2019

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011